The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

被引:4
|
作者
Kim, Jun Jae [1 ]
Kim, Jeong Han [1 ]
Koo, Ja Kyung [1 ]
Choi, Yun Jung [1 ]
Ko, Soon Young [1 ]
Choe, Won Hyeok [1 ]
Kwon, So Young [1 ]
机构
[1] Konkuk Univ, Sch Med, Digest Dis Ctr, Dept Internal Med, Seoul, South Korea
关键词
End Stage Liver Disease; Liver Cirrhosis; Ascites; Mortality; Hyponatremia;
D O I
10.3350/cmh.2014.20.1.47
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in 2011. We aimed to validate the superiority of the Refit MELDNa over the Refit MELD for the prediction of 3-month mortality in Korean patients with cirrhosis and ascites. Methods: We reviewed the medical records of patients admitted with hepatic cirrhosis and ascites to the Konkuk University Hospital between January 2006 and December 2011. The Refit MELD and Refit MELDNa were compared using the predictive value of the 3-month mortality, as assessed by the Child-Pugh score. Results: In total, 530 patients were enrolled, 87 of whom died within 3 months. Alcohol was the most common etiology of their cirrhosis (n= 271, 51.1%), and the most common cause of death was variceal bleeding (n= 20, 23%). The areas under the receiver operating curve (AUROCs) for the Child-Pugh, Refit MELD, and Refit MELDNa scores were 0.754, 0.791, and 0.764 respectively; the corresponding values when the analysis was performed only in patients with persistent ascites (n= 115) were 0.725, 0.804, and 0.796, respectively. The significant difference found among the Child-Pugh, Refit MELD, and Refit MELDNa scores was between the Child-Pugh score and Refit MELD in patients with persistent ascites (P= 0.039). Conclusions: Refit MELD and Refit MELDNa exhibited good predictability for 3-month mortality in patients with cirrhosis and ascites. However, Refit MELDNa was not found to be a better predictor than Refit MELD, despite the known relationship between hyponatremia and mortality in cirrhotic patients with ascites.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [21] Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
    Kim, Jeong Han
    Cho, Yong Joon
    Choe, Won Hyeok
    Kwon, So Young
    Yoo, Byung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02): : 248 - 260
  • [22] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40 (vol 77, pg 851, 2023)
    Tarlows, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 78 (04) : E84 - E84
  • [23] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [24] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [25] Liver Dysfunction by Model for End-Stage Liver Disease Score Improves Mortality Prediction in Injured Patients With Cirrhosis
    Corneille, Michael G.
    Nicholson, Susannah
    Richa, Jacqueline
    Son, Colin
    Michalek, Joel
    Wolf, Steven E.
    Stewart, Ronald
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2011, 71 (01): : 6 - 11
  • [26] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280
  • [27] Model for End-Stage Liver Disease: End of the First Decade
    Asrani, Sumeet K.
    Kim, W. Ray
    CLINICS IN LIVER DISEASE, 2011, 15 (04) : 685 - +
  • [28] A model to predict survival in patients with End-Stage Liver Disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, WK
    Therneau, TM
    D'Amico, G
    Kosberg, CL
    Dickson, ER
    Kim, WR
    GASTROENTEROLOGY, 2001, 120 (05) : A76 - A77
  • [29] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    HEPATOLOGY, 2001, 33 (02) : 464 - 470
  • [30] Reply: Clinically Relevant Differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-Sodium Scores
    Xiol, Xavier
    Castellote, Jose
    Fuentes-Arderiu, Xavier
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1904 - 1904